GET /api/v0.1/hansard/entries/1341073/?format=api
HTTP 200 OK
Allow: GET, PUT, PATCH, DELETE, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"id": 1341073,
"url": "https://info.mzalendo.com/api/v0.1/hansard/entries/1341073/?format=api",
"text_counter": 343,
"type": "speech",
"speaker_name": "Dr Susan Nakhumicha",
"speaker_title": "The Cabinet Secretary for Health",
"speaker": null,
"content": "The second part of the Question was whether Velo has been sneaked back to the market as a rebrand of Lyft, which is a similar drug that was banned back in 2020 by the Ministry of Health due to not meeting Parts I and II of the Pharmacy and Poisons Act. Hon. Members, I confirm that Velo is a rebrand of BAT's Lyft, which was recalled from the Kenyan market by BAT following a directive by the immediate former Cabinet Secretary. Velo hit the Kenyan market in June 2022 following a moratorium that was issued on 15th June 2022 by my immediate predecessor. Notably, the said Lyft was not banned but its registration and regulation were changed from the Pharmacy and Poisons Act, Cap 244 to regulation under the Tobacco Control Act, 2007."
}